Traumatic Brain Injury (TBI) is a significant health issue that occurs at a high rate in military populations. According to the Defense and Veterans Brain Injury Center, more than 380,000 Service members have been diagnosed with TBI since 2000. TBI is also a significant public health burden that most commonly is a result of car accidents, falls, or sports injuries [CDC]. The Department of defense (DoD) and Veterans Affairs (VA) ...
Continue Reading →
Does your company have a therapeutic candidate (small molecule, monoclonal antibody, combination product, or other) for the treatment of a type of cancer? Does your therapeutic candidate have multiple indications for multiple types of cancers (e.g., drugs targeting reactive oxygen species [ROS] or cell surface receptors [GPCRs, EGFR]; protein inhibitors [Hsp90, ATR kinase]; epigenetic enzymes [LSD1]; or combination therapies [erlotinib ...
Continue Reading →
The Department of Defense (DoD) and other military assisting Federal Agencies have a large and diverse community of subject matter experts (SME) who are eager to collaborate with industry and universities. These extraordinary SMEs are driven to accelerate new and novel dual-use technologies forward to clinical and operational settings. There are thousands of healthcare providers in 167 DoD medical treatment facilities within the U.S. (43 Army MTFs); tens of thousands of researchers in the
Continue Reading →
There are many types of Cooperative R&D Agreement (CRADA) instruments and processes used by the Department of Defense (DoD), Department of Veterans Affairs (VA) and other Federal Agencies. Each type of CRADA presents a different mechanism or path to establishing meaningful and long-term collaborations between Federal and non-Federal entities to foster R&D innovation and improve the transition and commercialization of required technologies. This list of the types of CRADAs utilized by the DoD and VA is not ...
Continue Reading →
Cooperative R&D agreements (CRADAs) and other DoD technology transfer mechanisms (e.g., licensing, patents, and publishing) help to convey knowledge, ownership rights, or establish formal research agreements between Federal and non-Federal entities. Of these instruments, CRADAs provide a convenient mechanism for these entities to collaborate, but how many CRADAs are completed by each Federal entity each year?
Asking questions like this is important for a company when considering if they should build a long-term business relationship with ...
Continue Reading →